BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 8954107)

  • 1. Phytanoyl-CoA hydroxylase is present in human liver, located in peroxisomes, and deficient in Zellweger syndrome: direct, unequivocal evidence for the new, revised pathway of phytanic acid alpha-oxidation in humans.
    Jansen GA; Mihalik SJ; Watkins PA; Moser HW; Jakobs C; Denis S; Wanders RJ
    Biochem Biophys Res Commun; 1996 Dec; 229(1):205-10. PubMed ID: 8954107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of pristanal dehydrogenase activity in peroxisomes: conclusive evidence that the complete phytanic acid alpha-oxidation pathway is localized in peroxisomes.
    Jansen GA; van den Brink DM; Ofman R; Draghici O; Dacremont G; Wanders RJ
    Biochem Biophys Res Commun; 2001 May; 283(3):674-9. PubMed ID: 11341778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resolution of the phytanic acid alpha-oxidation pathway: identification of pristanal as product of the decarboxylation of 2-hydroxyphytanoyl-CoA.
    Verhoeven NM; Schor DS; ten Brink HJ; Wanders RJ; Jakobs C
    Biochem Biophys Res Commun; 1997 Aug; 237(1):33-6. PubMed ID: 9266824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phytanic acid must be activated to phytanoyl-CoA prior to its alpha-oxidation in rat liver peroxisomes.
    Watkins PA; Howard AE; Mihalik SJ
    Biochim Biophys Acta; 1994 Oct; 1214(3):288-94. PubMed ID: 7918611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phytanic acid activation in rat liver peroxisomes is catalyzed by long-chain acyl-CoA synthetase.
    Watkins PA; Howard AE; Gould SJ; Avigan J; Mihalik SJ
    J Lipid Res; 1996 Nov; 37(11):2288-95. PubMed ID: 8978480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of phytanic acid omega-hydroxylation in human liver microsomes.
    Komen JC; Duran M; Wanders RJ
    Mol Genet Metab; 2005 Jul; 85(3):190-5. PubMed ID: 15979030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2-Hydroxyphytanic acid oxidase activity in rat and human liver and its deficiency in the Zellweger syndrome.
    Wanders RJ; van Roermund CW; Schor DS; ten Brink HJ; Jakobs C
    Biochim Biophys Acta; 1994 Nov; 1227(3):177-82. PubMed ID: 7986825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phytanic acid alpha-oxidation in rat liver peroxisomes. Production of alpha-hydroxyphytanoyl-CoA and formate is enhanced by dioxygenase cofactors.
    Mihalik SJ; Rainville AM; Watkins PA
    Eur J Biochem; 1995 Sep; 232(2):545-51. PubMed ID: 7556205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peroxisomes, Refsum's disease and the alpha- and omega-oxidation of phytanic acid.
    Wanders RJ; Komen JC
    Biochem Soc Trans; 2007 Nov; 35(Pt 5):865-9. PubMed ID: 17956234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phytanic acid oxidation: topographical localization of phytanoyl-CoA ligase and transport of phytanic acid into human peroxisomes.
    Pahan K; Singh I
    J Lipid Res; 1995 May; 36(5):986-97. PubMed ID: 7544821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxisomal disorders affecting phytanic acid alpha-oxidation: a review.
    Wierzbicki AS
    Biochem Soc Trans; 2007 Nov; 35(Pt 5):881-6. PubMed ID: 17956237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CYP4 isoform specificity in the omega-hydroxylation of phytanic acid, a potential route to elimination of the causative agent of Refsum's disease.
    Xu F; Ng VY; Kroetz DL; de Montellano PR
    J Pharmacol Exp Ther; 2006 Aug; 318(2):835-9. PubMed ID: 16707724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phytanic acid alpha-oxidation in man: identification of 2-hydroxyphytanoyl-CoA lyase, a peroxisomal enzyme with normal activity in Zellweger syndrome.
    Jansen GA; Denis S; Verhoeven NM; Jakobs C; Wanders RJ
    J Inherit Metab Dis; 2000 Jun; 23(4):421-4. PubMed ID: 10896309
    [No Abstract]   [Full Text] [Related]  

  • 14. Phytanoyl-CoA hydroxylase from rat liver. Protein purification and cDNA cloning with implications for the subcellular localization of phytanic acid alpha-oxidation.
    Jansen GA; Ofman R; Denis S; Ferdinandusse S; Hogenhout EM; Jakobs C; Wanders RJ
    J Lipid Res; 1999 Dec; 40(12):2244-54. PubMed ID: 10588950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraorganellar localization of CoASH-independent phytanic acid oxidation in human liver peroxisomes.
    Pahan K; Singh I
    FEBS Lett; 1993 Oct; 333(1-2):154-8. PubMed ID: 8224157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant subcellular localization of peroxisomal 3-ketoacyl-CoA thiolase in the Zellweger syndrome and rhizomelic chondrodysplasia punctata.
    Balfe A; Hoefler G; Chen WW; Watkins PA
    Pediatr Res; 1990 Mar; 27(3):304-10. PubMed ID: 2181395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phytanic acid oxidation: normal activation and transport yet defective alpha-hydroxylation of phytanic acid in peroxisomes from Refsum disease and rhizomelic chondrodysplasia punctata.
    Pahan K; Khan M; Singh I
    J Lipid Res; 1996 May; 37(5):1137-43. PubMed ID: 8725164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utilization of sterol carrier protein-2 by phytanoyl-CoA 2-hydroxylase in the peroxisomal alpha oxidation of phytanic acid.
    Mukherji M; Kershaw NJ; Schofield CJ; Wierzbicki AS; Lloyd MD
    Chem Biol; 2002 May; 9(5):597-605. PubMed ID: 12031666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The metabolism of phytanic acid and pristanic acid in man: a review.
    Verhoeven NM; Wanders RJ; Poll-The BT; Saudubray JM; Jakobs C
    J Inherit Metab Dis; 1998 Oct; 21(7):697-728. PubMed ID: 9819701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural and mechanistic studies on the peroxisomal oxygenase phytanoyl-CoA 2-hydroxylase (PhyH).
    Schofield CJ; McDonough MA
    Biochem Soc Trans; 2007 Nov; 35(Pt 5):870-5. PubMed ID: 17956235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.